Impact of metabolic syndrome on ischemic heart disease - A prospective cohort study in an Iranian adult population: Isfahan cohort study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 5, 2012, Pages 434-441

  Talaei, M ^a   Sadeghi, M ^a   Marshall, T ^b   Thomas, G N ^b   Kabiri, P ^c   Hoseini, S ^a   Sarrafzadegan, N ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Ischemic heart disease; Longitudinal study; Metabolic syndrome

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEVELOPING COUNTRY; ETHNOLOGY; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INCIDENCE; IRAN; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SURVIVAL; WAIST CIRCUMFERENCE;

ADULT; AGED; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; INCIDENCE; IRAN; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OBESITY, ABDOMINAL; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS; WAIST CIRCUMFERENCE;

ANGINA;

EID: 84859994540     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.08.003     Document Type: Article

References (35)

1. Sarrafzadegan N., Kelishadi R., Esmaillzadeh A., Mohammadifard N., Rabiei K., Roohafza H., et al. Do lifestyle interventions work in developing countries? Findings from the Isfahan healthy heart program in the Islamic Republic of Iran. Bull World Health Organ 2009, 87:39-50.
2. Park H.S., Cho S.I., Song Y.M., Sung J. Multiple metabolic risk factors and total and cardiovascular mortality in men with low prevalence of obesity. Atherosclerosis 2006 Jul, 187(1):123-130.
3. Wilson P.W.F., D'Agostino R.B., Parise H., Sullivan L., Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112(20):3066-3072.
4. Pan W.H., Yeh W.T., Weng L.C. Epidemiology of metabolic syndrome in Asia. Asia Pac J Clin Nutr 2008, 17(Suppl. 1):37-42.
5. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic sydrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49(4):403-414.
6. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28(7):1769-1778.
7. Galassi A., Reynolds K., He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006, 119(10):812-819.
8. Sarraf-Zadegan N., Sadri G., Malek A.H., Baghaei M., Mohammadi F.N., Shahrokhi S., et al. Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol 2003, 58(4):309-320.
9. Vartiainen E., Laatikainen T. Isfahan Healthy heart Program (IHHP): external evaluation 12.5.-18.5.2009 [Internet] 2009, [cited 2009 Jun 25], Isfahan Cardiovascular Research Center, Isfahan, Available from:. http://ihhp.mui.ac.ir/ihhp/sounds/1656/1656_0.pdf.
10. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome. An American heart Association/National heart, Lung, and blood Institute Scientific statement. Executive summary. Cardiol Rev 2005, 13(6):322-327.
11. Yang G., Rao C., Ma J., Wang L., Wan X., Dubrovsky G., et al. Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol 2006, 35(3):741-748.
12. Kumar R., Thakur J.S., Rao B.T., Singh M.M., Bhatia S.P. Validity of verbal autopsy in determining causes of adult deaths. Indian J Public Health 2006, 50(2):90-94.
13. Luepker R.V., Apple F.S., Christenson R.H., Crow R.S., Fortmann S.P., Goff D., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and prevention; AHA Statistics Committee; World heart Federation Council on Epidemiology and prevention; the European Society of Cardiology Working group on Epidemiology and prevention; Centers for disease control and prevention; and the national heart, Lung, and blood Institute. Circulation 2003, 108(20):2543-2549.
14. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American heart association Task Force on Practice guidelines (Committee on the management of patients with unstable angina). Circulation 2002, 106(14):1893-1900.
15. Alberti K.G.M., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366(9491):1059-1062.
16. Wierzbicki A.S., Nishtar S., Lumb P.J., Lambert-Hammill M., Crook M.A., Marber M.S., et al. Waist circumference, metabolic syndrome and coronary artery disease in a Pakistani cohort. Int J Cardiol 2008, 128(1):77-82.
17. Onat A., Ceyhan Kk, Basar O., Erer B., Toprak S., Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 2002, 165(2):285-292.
18. Iso H., Sato S., Kitamura A., Imano H., Kiyama M., Yamagishi K., et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007, 38(6):1744-1751.
19. Chien K.L., Hsu H.C., Sung F.C., Su T.C., Chen M.F., Lee Y.T. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 2007, 194(1):214-221.
20. Thomas G.N., Schooling C.M., McGhee S.M., Ho S.Y., Cheung B.M., Wat N.M., et al. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong cardiovascular risk factor study. Clin Endocrinol (Oxf) 2007, 66(5):666-671.
21. Eberly L.E., Prineas R., Cohen J.D., Vazquez G., Zhi X., Neaton J.D., et al. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 2006 1, 29(1):123-130.
22. McNeill A.M., Rosamond W.D., Girman C.J., Golden S.H., Schmidt M.I., East H.E., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28(2):385-390.
23. Hillier T.A., Rousseau A., Lange C., Lepinay P., Cailleau M., Novak M., et al. Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Diabetologia 2006, 49(7):1528-1535.
24. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study. Eur J Cardiovasc Prev Rehabil 2007, 14(2):192-199.
25. Woodward M., Tunstall-Pedoe H. The metabolic syndrome is not a sensible tool for predicting the risk of coronary heart disease. Eur J Cardiovasc Prev Rehabil 2009, 16(2):210-214.
26. Nilsson P.M. Cardiovascular risk in the metabolic syndrome: fact or fiction?. Curr Cardiol Rep 2007, 9(6):479-485.
27. World Health Organization (WHO) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894. i-253.
28. Delavari A., Forouzanfar M.H., Alikhani S., Sharifian A., Kelishadi R. The First nationwide study of the prevalence of the metabolic syndrome and optimal cut-off points of waist circumference in the middle east: the national survey of risk factors for non-communicable diseases of Iran. Diabetes Care 2009, dc08-1800.
29. Esteghamati A., Ashraf H., Rashidi A., Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract 2008, 82(1):104-107.
30. Zimmet P., Alberti K.G., Serrano Rios M. A New International Diabetes Federation (IDF) worldwide definition of the metabolic syndrome: the rationale and the results. Revista Espanola de Cardiologia 2005, 58(12):1371-1375.
31. Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28(9):2289-2304.
32. Zabetian A., Hadaegh F., Azizi F. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women. Exp Clin Endocrinol Diabetes 2008, 116(9):525-531.
33. Dekker J.M., Girman C., Rhodes T., Nijpels G., Stehouwer C.D.A., Bouter L.M., et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation 2005, 112(5):666-673.
34. He Y., Lam T.H., Jiang B., Wang J., Sai X., Fan L., et al. Combined effects of tobacco smoke exposure and metabolic syndrome on cardiovascular risk in older residents of China. J Am Coll Cardiol 2009, 53(4):363-371.
35. Nakamura K., Barzi F., Huxley R., Lam T.H., Suh I., Woo J., et al. Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?. Heart 2009, 95(11):909-916.